Thomas A. Colacchio

Medicine · Health Sciences

29h-index3.5kcitations88works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pancreatic and Hepatic Oncology Research(23), Ultrasound and Hyperthermia Applications(17), Colorectal Cancer Treatments and Studies(17), Neuroendocrine Tumor Research Advances(10), Cancer Genomics and Diagnostics(10)

Publications88 total

Better Patient and Population Outcome
2022
Effect of intraoperative secretin on operative outcomes in pancreatic resection: A randomized controlled trial
Pancreatology·2021· 2 citedOpen Access
Documenting the Natural History of Patients With Resected Stage II Adenocarcinoma of the Colon After Random Assignment to Adjuvant Treatment With Edrecolomab or Observation: Results From CALGB 9581
UNC Libraries·2020Open Access
Microsatellite Instability and Loss of Heterozygosity at Chromosomal Location 18q: Prospective Evaluation of Biomarkers for Stages II and III Colon Cancer—A Study of CALGB 9581 and 89803
UNC Libraries·2020Open Access
Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance)
UNC Libraries·2020Open Access
Reply to L. Casadaban et al
Journal of Clinical Oncology·2017
A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803
The Oncologist·2016· 20 citedOpen Access
Abstract A24: Early-stage pancreatic cancer patient derived xenograft (PDX) models established from endoscopic ultrasound (EUS) fine needle aspiration (FNA) biopsies
Clinical Cancer Research·2016
Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance)
Journal of Clinical Oncology·2016· 57 citedOpen Access
Cost-effectiveness and clinical efficacy of biliary stents in patients undergoing neoadjuvant therapy for pancreatic adenocarcinoma in a randomized controlled trial
Gastrointestinal Endoscopy·2016· 103 cited
Genomic characterization of patient-derived xenograft models established from fine needle aspirate biopsies of a primary pancreatic ductal adenocarcinoma and from patient-matched metastatic sites
Oncotarget·2016· 43 citedOpen Access
Invited Commentary
Journal of the American College of Surgeons·2015
The Effect of Neoadjuvant Chemoradiation on Pancreatic Cancer-Associated Diabetes Mellitus
Pancreas·2014· 11 cited
Effects of dose reduction on gemcitabine-based neoadjuvant chemoradiotherapy for localized pancreatic cancer.
Journal of Clinical Oncology·2014
Prognostic value of serum carbohydrate 19-9 in patients receiving gemcitabine-based neoadjuvant therapy for pancreatic cancer.
Journal of Clinical Oncology·2014· 1 cited
Invited Commentary
Journal of the American College of Surgeons·2014
Molecular Profiling of Appendiceal Epithelial Tumors Using Massively Parallel Sequencing to Identify Somatic Mutations
Clinical Chemistry·2014· 87 cited
Association between ColDx assay result and recurrence-free interval in stage II colon cancer patients on CALGB (Alliance) 9581.
Journal of Clinical Oncology·2014· 7 cited
Pancreatic Cyst Prevalence and the Risk of Mucin-Producing Adenocarcinoma in US Adults
The American Journal of Gastroenterology·2013· 137 citedOpen Access
Mo1426 The Effect of Neoadjuvant Chemoradiation on Pancreatic Cancer Associated Diabetes Mellitus
Gastroenterology·2013Open Access
page 1 of 5Next →

Frequent Co-authors

Richard J. Barth(14), Donna Niedzwiecki(8), Robert J. Mayer(8), Richard M. Goldberg(8), Gregory H. Ripple(8), Michael J. Tsapakos(8), Stuart R. Gordon(8), Timothy B. Gardner(7), Kerrington D. Smith(7), Arief A. Suriawinata(7), Bassem I. Zaki(7), Robert S. Warren(6), J. Marc Pipas(6), John E. Sutton(6), S.M. Gillette(6), Edward L. Gillette(6), Monica M. Bertagnolli(5), Carolyn C. Compton(5), Thomas P. Ryan(5), Gregory J. Tsongalis(4)